EN
HI

AKUMS DRUGS AND PHARMA L Share price

AKUMS

HealthcareMid

546.4

11.60 (-2.08%)
NSE
BSE
Last updated on 16 May, 2025 | 15:31 IST
BUYSELL
Today's High

561.75

Today's Low

540.75

52 Week Low

405.00

52 Week High

1175.90

The current prices are delayed, login to your account for live prices

Akums Drugs & Pharmaceuticals Chart

AKUMS DRUGS AND PHARMA L Fundamentals

P/E Ratio

0

P/B Ratio

3.78

Div. Yield

0

Sector P/E

41.98

Sector P/B

4.77

Sec. Div. Yield

0.33

AKUMS DRUGS AND PHARMA L Resistance and Support

Pivot 545.53

Resistance

First Resistance

574.96

Second Resistance

591.93

Third Resistance

621.36

Support

First Support

528.56

Second Support

499.13

Third Support

482.16

AKUMS DRUGS AND PHARMA L Futures & Options

Data Not Found

AKUMS DRUGS AND PHARMA L Shareholding Pattern

    Total Promoters
    Segment
    Percent

    Total Promoters

    75.26%

    Mutual Fund

    6.11%

    Insurance

    0.66%

    Foreign Institutional Investors

    5.77%

    Domestic Institutional Investors

    0.63%

    Retail

    11.58%

    Others

    -0.01%

    Total Promoters
    MAR '25
    75.26%

    AKUMS DRUGS AND PHARMA L Corporate Actions

    DateAgenda
    2025-02-06Quarterly Results
    DateEvent TypeAgenda
    2025-02-06Board MeetingQuarterly Results

    AKUMS DRUGS AND PHARMA L News

    No Data Found

    About AKUMS DRUGS AND PHARMA L AboutThe

    NSE : 24715  
    BSE : 544222  
    ISIN : INE09XN01023  

    Our Company was incorporated as a public limited company under the Companies Act 1956 as ‘Akums Drugs and Pharmaceuticals Limited’ pursuant to a certificate of incorporation dated April 19 2004 issued by the RoC. Our Company received a certificate for commencement of business issued by the RoC dated May 13 2004.Major Events and Milestones:2004-Incorporation of the Company-Established first plant for oral dosage commissioned at 19 20 21 sector 6A Haridwar Uttarakhand2007-Established dedicated manufacturing site for oral liquid dosage at 22 Sector 6A Sidcul Haridwar Uttarakhand and sterile products at 2345 Sector 6B SIDCUL Haridwar Uttarakhand2009-Incorporated Maxcure Nutravedics Limited to venture into nutraceuticals2010-Dedicated a facility for hormones at 48 Sector 6A SIDCUL Haridwar Uttarakhand-Dedicated a facility for cosmetics and dermatology at 47 Sector 6A SIDCUL Haridwar Uttarakhand-Incorporated Akumentis Healthcare Limited to venture into branded formulations2011-Innovated bi-layered sustained release tablets for the first time2012-Acquired Pure and Cure Healthcare Private Limited to expand capacity and capabilities2013-Innovated tablet-in-tablet sustained release tablets for the first time-Acquired Malik Lifesciences Private Limited manufacturing sites to expand capacity and capabilities-Expanded into the African market2015-Expanded into the Asian market-Established research and development laboratory in Mumbai Maharashtra to venture into regulated market2016-Maxcure Nutravedics Limited received US-NSF certification2019-Investment by Ruby QC Investment Holdings Pte. Ltd. in our Company to become a minority shareholder2021-Acquired Parabolic Drugs to form Akums Lifesciences Limited and ventured into APIs-Acquisition of a facility at Kotdwar Uttarakhand by Akums Healthcare Limited2022-Plant at 19 20 21 Sector 6A SIDCUL Haridwar Uttarakhand and plant at 2 3 45 Sector 6B SIDCUL Haridwar Uttarakhand accredited European Union-Good Manufacturing Practices qualifying for exports to European markets-Acquisition of a facility in Haridwar Uttarakhand by Akums Healthcare Limited and a facility in Baddi Himachal Pradesh by Pure and Cure Healthcare Private Limited2023-Acquisition of another facility in Baddi Himachal Pradesh by Pure and Cure Healthcare Private Limited-Merger of Akums Lifesciences Limited with Pure and Cure Healthcare Private Limited

    AKUMS DRUGS AND PHARMA L Management

    NamePosition
    Mr. Sanjeev Jain Managing Director
    Mr. Sandeep Jain Managing Director
    Mr. Sanjay Sinha Whole Time Director
    Mr. Sunil Kumar Thakur Non Exe. & Nominee Director
    Ms. Matangi Gowrishankar Independent Director
    Read More

    AKUMS DRUGS AND PHARMA L FAQs

    AKUMS DRUGS AND PHARMA L शेयर का खरीद मूल्य 546.4 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

    AKUMS DRUGS AND PHARMA L शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

    AKUMS DRUGS AND PHARMA L शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 0 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

    AKUMS DRUGS AND PHARMA L शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.78 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

    AKUMS DRUGS AND PHARMA L शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 4.77 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

    AKUMS DRUGS AND PHARMA L का मार्केट कैप 8600.01 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

    AKUMS DRUGS AND PHARMA L शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 1175.90 और 405.00 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

    AKUMS DRUGS AND PHARMA L Share Key Metrics

    Volume
    2.36 L
    Market Cap
    8600.01 CR
    LTQ@LTP
    35@546.40
    ATP
    548.48
    Var Margin
    19.85 %
    Circuit Range
    502.2-613.8
    Delivery %
    37.98 %
    Value
    12.94 CR
    ASM/GSM
    No
    Market Lot
    1